Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Clever Leaves Holdings Inc

Cronos Group

Flora Growth Corp

GrowGeneration Corp

Hydrofarm Holdings Group

Incannex Healthcare Inc

Jazz Pharmaceuticals

OrganiGram Holdings Inc.

Village Farms International

The Valens Co

Zynerba Pharmaceuticals

Welcome back to our weekly series,  Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks, and look at how the cannabis industry is evolving as we make our way through 2022.

Cannabis Sector Kicks Off March With a Blast of Q4 Earnings

Aurora Cannabis

Canopy Growth

Are These Canadian Cannabis Stocks A Buy At These Levels? The post Best Marijuana Stocks To Watch This Week? 3 Canadian Pot Stocks For Your List Right Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Best Marijuana Stocks To Watch This Week? 3 Canadian Pot Stocks For Your List Right Now

HEXO Corp

A day after Tilray Inc (NASDAQ: TLRY) announced a strategic partnership with Hexo Corp (TSE: HEXO), Canaccord Genuity upgraded both cannabis companies to “buy”. How does the deal benefit Tilray stock?

Tilray stock: Canaccord Genuity sees a 75% upside

Tilray is acquiring a portion of Hexo's debt. Here's what investors in HEXO, TLRY stocks should know about the collaboration between the two.

HEXO, TLRY Stocks: 8 Things to Know About the New Deal Linking Hexo and Tilray

Tilray Brands on Thursday agreed to buy up to $211 million of HEXO's debt, giving the Canadian cannabis producer a right to pick a significant equity stake in its troubled rival.

Cannabis producer Tilray to buy rival HEXO's debt of up to $211 million

Tilray Inc. (NASDAQ: TLRY) shares are trading lower Thursday and are continuing the downward trend the stock has been on. Tilray announced this morning that it would be entering a strategic partnership with HEXO Corp (NASDAQ: HEXO), which includes a new debt financing agreement.

Tilray Continues To Crash After Partnership Announcement: What's Next?

Tilray Brands Inc. TLRY, -0.34% TLRY, -1.34% said Thursday it would buy up to C$211 million ($167 million) of Hexo Corp. HEXO, +5.82% HEXO, +4.29% senior secured convertible notes held by HT Investments MA LLC as part of a strategic alliance between the two cannabis companies. Tilray would have the right to convert the debt into stock at a price of 90 cents per Hexo share.

Tilray agrees to buy up to $C211 mln in Hexo debt

HEXO to Restructure Balance Sheet, Including Sale of Amended Senior Secured Convertible Notes to Tilray Brands, Significantly Improving Flexibility and Reinvigorating HEXO's Path Forward Strategy HEXO to Restructure Balance Sheet, Including Sale of Amended Senior Secured Convertible Notes to Tilray Brands, Significantly Improving Flexibility and Reinvigorating HEXO's Path Forward Strategy

HEXO and Tilray Brands Agree to Create Strategic Alliance Bringing Together Two Canadian Cannabis Leaders

Tilray to Acquire Hexo Corp.'s Senior Secured Convertible Notes Tilray to Acquire Hexo Corp.'s Senior Secured Convertible Notes

Tilray Brands Announces Proposed Agreement for Strategic Alliance With Hexo Corp.

Pioneers in Hemp and Natural Foods Will Present ‘THE POWER OF HEMP' and Introduce New Products at Expo West March 10 – 12, 2022 Pioneers in Hemp and Natural Foods Will Present ‘THE POWER OF HEMP' and Introduce New Products at Expo West March 10 – 12, 2022

Manitoba Harvest to Unveil New Superfood Lineup

3 Marijuana Stocks To Watch March 1st The post 3 Canadian Marijuana Stocks To Watch This March appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

3 Canadian Marijuana Stocks To Watch This March

Arena Pharmaceuticals

High Tide

FSD Pharma

Innovative Industrial Properties

22nd Century Group

cbdMD Inc

WM Technology

11 Marijuana Stocks on Fire to Close February

The SAFE Banking Act may be the catalyst that long-suffering investors in TLRY stock have been waiting for, but it pales in comparison to legalization. The post Is it Finally SAFE to Invest in Tilray Stock?

Is it Finally SAFE to Invest in Tilray Stock?

Lucid Group

If investors are looking for a better risk-off trade, it may be time to consider three out-of-favor, deeper bear markets as stocks to buy. The post 3 Stocks to Buy in This Bear Market appeared first on InvestorPlace.

3 Stocks to Buy in This Bear Market

They haven't been good investments for quite some time.

Got $5,000? Please Don't Put It in These 2 Cannabis Growth Stocks

SNDL Inc.

Are These Pot Stocks Going To See Upside In March? The post Top Canadian Marijuana Stocks In February 2022 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Canadian Marijuana Stocks In February 2022

Cisco Systems

Exxon Mobil

Could these top cyclical stocks take precedence over the competition during this Presidents Day week?

3 Cyclical Stocks To Watch This Week

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

AdvisorShares Pure US Cannabis ETF

Trulieve Cannabis Corp.

Do Politics Affect Cannabis' Long-Term Growth Story? (Transcript)

Legalization. It's not just for marijuana anymore.

Why Marijuana Stocks Got Stubbed Out Today

Intercure Ltd

Evogene

These Pot Stocks Made Major International Moves This Week

The downward trend on TLRY stock might soon come to an end, amid an encouraging financial picture and increasing rumors that the cannabis legislation is close to a loosening in its core markets. The post Tilray' Downtrend Should Soon Come to an End appeared first on InvestorPlace.

Tilray' Downtrend Should Soon Come to an End

Tilray Medical's portfolio of medical cannabis brands includes Tilray, Aphria, Broken Coast, and Symbios. Tilray grew from being one of the first companies to become an approved licensed producer of medical cannabis in Canada to building the first GMP-certified cannabis production facilities in Europe, first in Portugal and later in Germany.

Tilray Launches Medical Cannabis Products In Malta.

LEAMINGTON, Ontario, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life, today announced that its medical cannabis division, Tilray Medical, has completed its first sale of medical cannabis in Malta. Tilray's EU-GMP medical cannabis products are now available in pharmacies across Malta, providing patients with safe and reliable access to high-quality medical cannabis.

Tilray Launches Medical Cannabis Products in Malta

Federal cannabis legalization is not the end all, be all - investors would be wise to think it will take longer than expected.

Do Politics Affect Cannabis' Long-Term Growth Story?

There's a promising development in one U.S. state.

Why Marijuana Stocks Like Aurora Cannabis Rose So Much Today

News for Tilray Brands Stock (TLRY)